PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients
Open Access
- 14 October 2008
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 99 (8), 1276-1284
- https://doi.org/10.1038/sj.bjc.6604665
Abstract
The immunosuppressant azathioprine is used to prevent graft rejection after organ transplantation. To investigate whether azathioprine-associated mutagenesis contributes to the high incidence of skin tumours in organ transplant recipients (OTRs), we analysed PTCH gene mutations in 60 basal cell carcinomas (BCC); 39 from OTRs receiving azathioprine and 21 from individuals never exposed to azathioprine. PTCH was mutated in 55% of all tumours, independent of azathioprine treatment. In both the azathioprine and non-azathioprine groups, transitions at dipyrimidine sequences, considered to indicate mutation by ultraviolet-B radiation, occurred frequently in tumours from chronically sun-exposed skin. In BCC from non-sun-exposed skin of azathioprine-treated patients, there was an over-representation of unusual G:C to A:T transitions at non-dipyrimidine sites. These were exclusive to the azathioprine-exposed group and all in the same TGTC sequence context at different positions within PTCH. Meta-analysis of 247 BCCs from published studies indicated that these mutations are rare in sporadic BCC and had never previously been reported in this specific sequence context. This study of post-transplant BCC provides the first indication that azathioprine exposure may be associated with PTCH mutations, particularly in tumours from non-sun-exposed skin.Keywords
This publication has 48 references indexed in Scilit:
- Skin cancer and solar UV radiationEuropean Journal Of Cancer, 1999
- p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomarivus statusOncogene, 1997
- Molecular pathology in basal cell cancer with p53 as a genetic markerOncogene, 1997
- Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.1997
- Basal Cell Carcinomas in Mice Overexpressing Sonic HedgehogScience, 1997
- Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident.1997
- Mutations in the human homologue of Drosophila patched (PTCH) in basal cell carcinomas and the Gorlin syndrome: different in vivo mechanisms of PTCH inactivation.1996
- The role of the human homologue of Drosophila patched in sporadic basal cell carcinomasNature Genetics, 1996
- Role of Postreplicative DNA Mismatch Repair in the Cytotoxic Action of ThioguanineScience, 1996
- Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus SyndromeScience, 1996